Home About Us Technology Management Contact Us
 
 
  NeuroQuest has discovered blood-based immune biomarkers for producing early and accurate
diagnostic and therapeutic tools for Alzheimer’s and ALS
(Lou Gehrig’s disease.)
 
   
NeuroQuest foresees a future where earlier testing of at-risk patients
for Alzheimer’s and ALS will open the window to a treatment
option that may slow and possibly reverse the effects of these
harrowing diseases.
   
 
 
Home About Us Technology Management Contact Us
 
 
 
Site By Imaginet